Establishing catalytic activity on an artificial (βα)8-barrel protein designed from identical half-barrels  by Sperl, Josef M. et al.
FEBS Letters 587 (2013) 2798–2805journal homepage: www.FEBSLetters .orgEstablishing catalytic activity on an artiﬁcial (ba)8-barrel protein
designed from identical half-barrels0014-5793/$36.00  2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
http://dx.doi.org/10.1016/j.febslet.2013.06.022
⇑ Corresponding author. Fax: +49 941 943 2813.
E-mail address: reinhard.sterner@ur.de (R. Sterner).Josef M. Sperl, Bettina Rohweder, Chitra Rajendran, Reinhard Sterner ⇑
Institute of Biophysics and Physical Biochemistry, University of Regensburg, Universitätsstrasse 31, D-93053 Regensburg, Germany
a r t i c l e i n f o a b s t r a c tArticle history:
Received 18 March 2013
Revised 27 May 2013
Accepted 16 June 2013
Available online 24 June 2013
Edited by Christian P. Whitman
Keywords:
Artiﬁcial enzyme
Enzyme design
Enzyme evolution
(ba)8-BarrelIt has been postulated that the ubiquitous (ba)8-barrel enzyme fold has evolved by duplication and
fusion of an ancestral (ba)4-half-barrel. We have previously reconstructed this process in the labo-
ratory by fusing two copies of the C-terminal half-barrel HisF-C of imidazole glycerol phosphate syn-
thase (HisF). The resulting construct HisF-CC was stepwise stabilized to Sym1 and Sym2, which are
extremely robust but catalytically inert proteins. Here, we report on the generation of a circular per-
mutant of Sym2 and the establishment of a sugar isomerization reaction on its scaffold. Our results
demonstrate that duplication and mutagenesis of (ba)4-half-barrels can readily lead to a stable and
catalytically active (ba)8-barrel enzyme.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Evolution has provided us with a myriad of enzymes which
catalyze an amazing wealth of different reactions with tremen-
dous selectivity and speciﬁcity. One of the most important and
frequent mechanisms for the creation of new enzymes is the
duplication of genes [13,28]. Following duplication, the new gene
copy can be either recruited for a new function, or it can be
fused with the original gene copy or with another nucleotide
fragment from the genome. Especially proteins that exhibit a
high degree of internal structure and sequence symmetry
suggest a scenario of duplication and fusion of identical gene
copies, with a conversion of symmetric oligomers into symmet-
ric monomers [38,53]. However, we can only claim a full under-
standing of the underlying mechanisms if we are able to build
stable and active proteins in the laboratory by reproducing
proposed gene duplication and fusion events. Along these lines,
recent advances in computational and rational design afforded
the creation of stable chimeric proteins by fusing gene fragments
from different proteins [10,16,42] or by generating completely
artiﬁcial proteins from scratch [24]. However, these artiﬁcial
proteins lacked measurable catalytic activity. In contrast, state-
of-the-art computational approaches have allowed for theintroduction of new, albeit weak enzymatic activities on existing
natural protein scaffolds [19,39,43]. Importantly, these weak
activities could be signiﬁcantly improved by directed laboratory
evolution, that is the combination of random mutagenesis with
powerful selection or screening techniques [2,22,23,47,48,51].
The (ba)8-barrel is one of the oldest, most versatile and ubiqui-
tous protein folds [52]. It is found in about 10% of all proteins with
known three-dimensional structure [14]. (ba)8-Barrel enzymes
can act as oxidoreductases, transferases, lyases, hydrolases and
isomerases, thereby covering ﬁve of the six enzyme commission
(EC) classes. The canonical barrel consists of at least 200 amino acids
grouped in eight units. Each unit contains a b-strand which is
connected to an a-helix via a ba-loop. The individual modules are
linked via ab-loops. The central barrel is formed by the eight
b-strands and surrounded by the eight a-helices. Residuesimpor-
tant for substrate speciﬁcity and catalysis are found at the C-termi-
nal ends of the b-strands and in the connecting ba-loops whereas
the remainder of the structure including the ab-loops on the oppo-
site face of the barrel are important for stability [45]. The modular
structure of the barrel suggests an evolutionary precursor that
consisted of (ba)n < 8-modules, and there are multiple hints indicat-
ing that modern (ba)8-barrels have evolved from (ba)2- and (ba)4-
fragments via gene duplication and fusion events [6,16,25,38]. In
particular, the strong fourfold and twofold internal symmetry of
the (ba)8-barrel enzymes N0-[(50-phosphoribosyl)formimino]-5-
aminoimidazole-4-carboxamide ribonucleotide (ProFAR) isomer-
ase (HisA) and imidazole glycerol phosphate synthase (HisF), which
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Fig. 1. Scheme for the isomerization of phosphoribosyl anthranilate (PRA) to 1-(2-carboxy-phenylamino)-10-deoxyribulose-50-phosphate (CdRP) by HisF-D130V + D176V
from T. maritima, and the reduction of CdRP to rCdRP by sodium borohydrate (NaBH4). The furanose ring oxygen of PRA is protonated by the carboxylic acid of the anthranilate
moiety (substrate assisted catalysis). The proton is most probably transferred via a water molecule (not shown for clarity) [37]. The C20 atom is then deprotonated by the
general base D11 facilitated by the Schiff base intermediate which acts as electron sink. The keto form of CdRP is ﬁnally formed by the spontaneous tautomerization of its
enolamine form. Reduction of CdRP with sodium borohydrate yields rCdRP.
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scenario [16,27]. We have previously reconstructed the proposed
evolutionary process of gene duplication from a (ba)4-half-barrel
to a (ba)8-barrel starting with the C-terminal half of HisF (HisF-C)
as a model for the original half-barrel [16,17,40]. Two copies of
HisF-C were fused to the HisF-CC construct, which was then stabi-
lized by a combination of rational design and directed evolution,
yielding the stable but inactive constructs Sym1 [17] and Sym2 [5].
Here we report on the next and ultimate step of reconstructing
(ba)8-barrel evolution by establishing enzymatic activity on the
artiﬁcial (ba)8-barrel protein Sym2. As model reaction we used
the isomerization of phophoribosyl anthranilate (PRA) to 1-(2-carb-
oxyphenylamino)-1-deoxyribulose-5-phosphate (CdRP), a trans-
formation that is catalyzed by the PRA isomerase (TrpF) within
tryptophan biosynthesis (Fig. 1). PRA isomerization is mechanisti-
cally rather simple [15,37] and has already been established on sev-
eral (ba)8-barrel enzymes including HisA, HisF [20,26], a HisAF
chimera [6], as well as the a-subunit of tryptophan synthase (TrpA)
[12]. In a ﬁrst step, we used rational design to establish binding of
reduced CdRP (rCdRP), which is a stable product analog of TrpF.
Subsequent to the successful introduction of a high afﬁnity binding
pocket for rCdRP on the Sym2 scaffold, randommutagenesis with a
very high error rate was performed to create PRA isomerase activ-
ity. In vivo selection of variant clones from the resulting library in
trpF-deﬁcient Escherichia coli cells identiﬁed an active Sym2 variant
that differed from the parental protein at nine amino acid positions.
After reducing the number of mutations upon keeping activity, we
ended upwith a symmetrical construct that contained only six ami-
no acid differences between the two fused (ba)4-half-barrels.
2. Materials and methods
2.1. Cloning of Sym2 variants
Cloning of the sym2 gene into vector pET24a(+) using NdeI, Bam-
HI, and XhoI restriction enzymes was described previously [5]. For
construction of the sym2_bindC gene, the 30-half-sequence of the
sym2 gene, sym2-C, was ﬁrst cloned into plasmid pET24a(+) usingBamHI and XhoI restriction sites [5] and mutated at position
D176C by QuikChange™ PCR [50] using the complementary oligo-
nucleotides 50-CCAGTATCGACAGAGTCGGCACAAA ATCGGG-30 and
50-CCCGATTTTGTGCCGACT CTG TCGATACTGG-30 as overlapping
primers (nucleotide exchange underlined), yielding sym2C-
D176VC. Subsequently, the sym2C-D130VC + D176VC sequence was
ampliﬁed by PCR using sym2C-D176VC as template. The oligonu-
cleotide 50-GGTCGC GGATCCCAG GCCGTTGTCGTGGCGA-
TAGTTGCAAAAAGAGTGGATGGAGAG-30 with a BamHI-site at the
50-terminus (underlined) and a nucleotide exchange (underlined)
was used as 50-primer, and the oligonucleotide 50-GCTAGT-
TATTGCTCAGCGG-30 was used as 30-primer. The ampliﬁed
fragment sym2C-D130VC + D176VC was cloned into pET24a(+)-
sym2 N [5] using BamHI and XhoI restriction sites, yielding
pET24a(+)-sym2_bindC. For construction of the sym2_bindN and
sym2_bindNC genes, the sym2N-D130VN + D176VN sequence was
ampliﬁed by PCR using sym2C-D130VC + D176VC as template. The
oligonucleotide 50-ATACATATGCAGCGCGTT GTCG TGGCGATA-30
with an NdeI-site at the 50-terminus (underlined) was used as
50-primer, and the oligonucleotide 50-CTGGGATCCGAAGGTCTGT-
GCGATTTGTGTGATGAGGCTCGGGTTTTCGACAGCGGCAGTATTGATA-
GAGACCTTGTCAGCACCTGCCAGGAAG-30 with a BamHI-site at the
30-terminus (underlined) was used as 30-primer. The ampliﬁed
fragment sym2N-D130VN + D176VN was cloned into pET24a(+)
using NdeI and BamHI restriction sites, yielding pET24a(+)-
sym2N-D130VN + D176VN. Next, sym2-C and sym2C-D130VC +
D176VC were cloned into pET24a(+)-sym2N-D130VN + D176VN to
yield pET24a(+)-sym2_bindN or pET24a(+)-sym2_bindNC, respec-
tively. The cpSym2_bindC gene was cloned from a modiﬁed pTNA
plasmid (see below) into a modiﬁed pET24a(+) vector using SphI
and HindIII restriction sites.
2.2. Generation of a plasmid-encoded cpSym2_bindC gene library with
randomized N-terminal half
The cpSym2_bindC gene was generated and cloned into a mod-
iﬁed plasmid, which was derived from pTNA [3,30] and allows for
constitutive expression in E. coli. The plasmid was constructed in
2800 J.M. Sperl et al. / FEBS Letters 587 (2013) 2798–2805two steps. First, a BsaI restriction site present in the ampicillin
resistance cassette of pTNA was eliminated by QuikChange™
mutagenesis with the complimentary oligonucleotides 50-
GCAATGATACCGCGCGACCCACGCTCACC-30 and 50-GGTGAGCGT
GGGTCGCGCGGTATCATTGC-30 as overlapping primers (nucleotide
exchanges underlined). Second, the plasmid pET24a(+)-hisF-
D130V + D176V [37] was used as template for the ampliﬁcation of
the 30-terminal half-sequence of cpSym2_bindC using 50-
GGCCTCGCATGCAGGGATCCGGTCTCACGACAAGGTGAGCATAAA-
CACGGCGGC-30 as 50-primer with a SphI-, BamHI- and BsaI-site
(underlined) and 50-CTCTGAAAGCTTAGTGGTGGTGGTGGTGGT-
GAGCGTCGGCACCTGCCAGGAAGGCTTCAAGG-30 as 30-primer with
a HindIII-site (underlined). The resulting fragment was cloned into
the modiﬁed pTNA via SphI and HindIII restriction sites, yielding
the plasmid pB4. Next, in order to introduce the randomized
50-terminal half-sequence of cpSym2_bindC, a second BsaI site
(underlined) was introduced via the oligonucleotides 50-
CTCGCGGACAAGGTGAGACCG-30 and 50-GATCCGGTCTCACCTTGT
CCGCGAGCATG-30, which were mixed and annealed by heating to
95 C and cooling down to room temperature in a water bath.
The annealed oligonucleotides were cloned into pB4 using SphI
and BamHI restriction sites to yield pExp-TrpF. The 50-terminal
sequence of cpSym2_bindC was subjected to epPCR in 16 reactions
with cumulative mutational burden [29]. The ﬁrst cup contained
the template which was the ampliﬁcation product of a PCR
reaction with the oligonucleotide 50-TCTCCGTG GGGTCTCAAAGGT-
GAGCATAAACACGGCGGCTG-30 with a BsaI-site (underlined) as
50-primer and the oligonucleotide 50-AAGCCGCAAGGTCT-
CAGTCGGCACCTGCCAGGAAGGCTTC-30 with a BsaI-site (under-
lined) as 30-primer and pET11c(+)-HisF [37] as template. The
epPCR reactions with the oligonucleotides 50-TCTCCGTGGGGT
CTCAAAGG-30 as 50-primer and 50- AAGCCGCAAGGTCTCAGTCG-30
as 30-primer contained unbalanced concentrations of nucleoside
triphosphates (0.2 mM ATP, 0.2 mM GTP, 1 mM CTP, 1 mM TTP),
together with 0.5 mM MnCl2 and 5.5 mM MgCl2. After four cycles
of ampliﬁcation 10 ll of the epPCR mixture of the ﬁrst reaction
were transferred to the next cup in order to avoid saturation. This
step was repeated until cup 16 was reached [29]. Reactions 7 to 16
were pooled in groups of three and used to purify the ampliﬁed
fragment. In order to get enough DNA for the cloning step, the
PCR products of the four groups were re-ampliﬁed in standard
PCR reactions. The ampliﬁcation products were puriﬁed from 1%
agarose gel. The mixture of randomized genes was then digested
with BsaI and the puriﬁed reaction products were ligated into the
pExp-TrpF plasmid, yielding the pExp-cpSym2_bindC library. The
ligation reaction was used to transform electro-competent DtrpF
Escherichia coli cells [44], which were then streaked out on SOC-
plates. The transformants were scraped off using a sterile spatula
and liquid LB medium, and the mixture of pExp-cpSym2 library
plasmids was prepared from the resulting cell suspension. The size
of the gene library was estimated by plating serial dilutions of the
transformed cells on small SOC-plates. Size and properties of the
resulting gene library are shown in Supplementary Table S1.
2.3. In vivo selection for TrpF-active cpSym2_bindC variants
In vivo complementation to select variants with TrpF activity
was performed essentially as described previously [6].
2.4. Analysis of beneﬁcial mutations
In order to replace each of the accumulated mutations individ-
ually by the wild-type sequence, the 50-terminal half-sequence of
cpSym2_sel was synthesized by GeneArt™ and subcloned via
blunt-ligation into a pUC19-derived vector. Subsequently, each
nucleotide exchange with regard to wild-type sequence wasreverted separately by QuikChange™ mutagenesis. The resulting
nine constructs were then cloned into pExp-TrpF via BsaI restric-
tion sites and tested for their ability to confer growth to DtrpF
E. coli cells.
2.5. Cloning of cpSym2_TrpF
We initially cloned the gene for the N-terminal half-barrel of
cpSym2_TrpF via blunt-end ligation into a pUC19-derived vector,
followed by several steps of QuikChange™mutagenesis to incorpo-
rate the mutations S101I, V140A, T171A and D176G. The resulting
construct was then cloned into pExp-TrpF via BsaI restriction sites.
The assembled full-length gene was ﬁnally subcloned via SphI and
HindIII restriction sites into a modiﬁed pET24a(+)-vector or the
pQE70-vector to allow for expression in E. coli T7-Express cells
(New England Biolabs) or DtrpF E. coli cells, respectively.
2.6. Expression of genes and puriﬁcation of recombinant proteins
The genes were expressed in E. coli T7-Express cells (New Eng-
land Biolabs) or DtrpF E. coli cells if contamination with wild-type
TrpF should be excluded. After induction with 0.5 mM IPTG, cells
were grown for 3 h at 37 C and harvested. Proteins were puriﬁed
as described for Sym2 by metal chelate afﬁnity chromatography
using the C-terminal His6-tag [5]. According to SDS–Page, the pur-
ity of all proteins was assessed >95%.
2.7. Functional characterization
The TrpF activity of puriﬁed cpSym2_TrpF was followed at 25 C
by a ﬂuorimetric assay and analyzed as described [18,46]. The
binding of the product analog rCdRP was followed by ﬂuorescence
energy transfer and analyzed as described [4,15].
2.8. Crystallization, data collection, and structure determination
Crystallization of cpSym2_TrpF was achieved in 96-well plates
(Nunc) using the hanging-drop vapor diffusion method at 291 K
and the PEG/Ion Screen™ (Hampton Research). Protein crystals
belonging to the space group SG P 1 21 1 grew within 8 days in a
drop containing 0.3 ll of 0.2 M Calcium acetate hydrate and 20%
(w/v) PEG 3350, mixed with 0.3 ll of protein cpSym2_TrpF
(17.9 mg/ml), to which 1 mM rCdRP was added. The drop was
equilibrated against 100 ll of reservoir buffer. Crystals were
ﬂash-frozen in nylon loops in liquid nitrogen. X-ray diffraction data
sets were collected with a PILATUS detector at the PXIII beamline
at SLS. The data processing was done using XDS [21] and the data
quality assessment was done using phenix.xtriage [1]. Molecular
replacement was performed with MOLREP within the CCp4i suite
[36] using the published high-resolution structure of Sym2 (PDB:
3OG3) as search model. Initial reﬁnement was performed using
REFMAC [32]. The model was further improved in several reﬁne-
ment rounds using automated restrained reﬁnement with the pro-
gram PHENIX [1] and interactive modeling with Coot [11]. The ﬁnal
model was analyzed using the programMolProbity [7]. Data collec-
tion and reﬁnement statistics are shown in Supplementary
Table S2.
3. Results and discussion
3.1. Introduction of a high afﬁnity rCdRP binding pocket on the Sym2
scaffold
In a ﬁrst step to establish TrpF activity on the Sym2 scaffold,
which is depicted in Fig. 2A, we focused on the introduction of a
binding site for the substrate PRA. Since it is difﬁcult to work with
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Fig. 2. Design of the artiﬁcial (ba)8-barrel protein Sym2 and variants thereof that bind rCdRP. (A) Secondary structure elements of Sym2. Parts that stem from the N-terminal
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pocket for rCdRP, which is a structurally similar and stable product
analog (Fig. 1). We knew from previous experiments that Thermo-
toga maritima HisF variants D130V and D176V show high afﬁnities
for rCdRP with thermodynamic dissociation constants (KD) of
about 0.2 lM [37]. Therefore, we constructed three variants in
which we introduced these exchanges in either the N- or the C-ter-
minal half (Sym2_bindN, Sym2_bindC), or in both halves
(Sym2_bindNC) of Sym2 (Fig. 2B). In contrast to Sym2, which does
not bind rCdRP, both Sym2_bindN and Sym2_bindC have reason-
able afﬁnities for rCdRP with KD values of 16 lM and 20 lM,
respectively (Fig. 3). Remarkably, the simultaneous introduction
of the D130V and D176V exchanges in both halves resulted in a
250-fold increased afﬁnity, yielding a KD-value for Sym2_bindNC
of 70 nM (Fig. 3). Encouraged by these results we tested whether
the three variants have the capacity to catalyze the TrpF reaction
in vivo as well as in vitro, but all turned out to be inactive. Never-
theless, the successful rational design of a high-afﬁnity binding
pocket for the product analog rCdRP provided us with a starting
point for the generation of PRA isomerization activity through ran-
dom mutagenesis.3.2. Activation of a circularly permutated variant of Sym2
Due to the high degree of internal symmetry in Sym2 and its
three rCdRP-binding competent variants it was not possible to per-
form randommutagenesis with the entire genes. PCR ampliﬁcation
would predominantly yield half-barrel genes due to duplicate
priming sites. Thus, we decided to randomize only one of the
two half-barrels and recombine it with the second, non-random-
ized half. In order to ﬁnd the most suitable construct for random-
ization we compared the sequences and structures of our three
Sym2 variants with HisF-D130V + D176V. This variant does not
only bind rCdRP, but also catalyzes the PRA isomerization reaction
[37]. Figs. 2 and 4 show that only Sym2_bindC shares a complete
(ba)4-unit with HisF-D130V + D176V. Therefore, we decided to in-
sert mutations in Sym2_bindC, however only in those four ba-units
which differ from HisF-D130V + D176V. Moreover, for ease of clon-
ing we performed a circular permutation, a step that is also used by
natural evolution [35,49], resulting in the construct cpSym2_bindC
(Fig. 4). In order to test whether circular permutation changed the
functional properties, cpSym2_bindC was produced and its afﬁnity
for rCdRP was quantiﬁed (Fig. 3). Remarkably, the determined
KD
rCdRP of 18 lM is practically identical to the KDrCdRP values of
Sym2_bindN and Sym2_bindC (Fig. 3). The ﬁrst half of cpSym2_-
bindC was randomly mutated via error-prone PCR (epPCR). We
used a high mutation rate with an average of 12 nucleotide ex-
changes per half-barrel gene as we wanted to sample as many
combinations of amino acid substitutions as possible. Usually, such
a high mutagenesis rate would impair the structure of the protein
[8]. However, the Sym2 scaffold has an extremely high stability [5],
for which reason we considered the chance of ﬁnding activating
amino acid exchanges higher than the risk of denaturing the whole
protein structure. The ampliﬁcation products of the error-prone
PCR with the ﬁrst half of cpSym2_bindC were subsequently com-
bined with the second, non-randomized half containing the
D130VC and D176VC exchanges (Fig. 5A). The entire gene repertoire
was cloned into the pTNA plasmid [3], and used to transform elec-
tro-competent E. coli cells. The resulting cpSym2_bindC gene li-
brary comprised 5  106 independent variants. Taking into
account that 42% of the variants contain a stop codon and thus
are truncated, non-functional protein, approximately 2  106
potentially folded variants remained (Supplementary Table S1).
To select for functional variants in our cpSym2_bindC library we
used an auxotrophic DtrpF E. coli strain which lacks the ability to
synthesize tryptophan [44]. Subsequent to the transformation of
DtrpF cells with the cpSym2_bindC library we identiﬁed a single
variant featuring PRA isomerization activity, by its ability to
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Fig. 4. Design of the starting construct for random mutagenesis cpSym2_bindC. (A) TrpF-active HisF variant HisF-D130V + D176V. The N-terminal half-barrel is shown in red
together with residue D11 which acts as general base during catalysis (Fig. 1); the C-terminal half-barrel is shown in blue. Amino acid exchanges leading to PRA isomerization
are indicated. (B) rCdRP-binding variant Sym2_bindC shares a complete half-barrel with HisF-D130V + D176V, as indicated by dotted lines. (C) Variant cpSym2_bindC was
circularly permutated to facilitate randomization of one half leaving the shared half-barrel untouched.
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Fig. 5. Library design, selection and amino acid exchanges required for PRA isomerization. (A) Schematic representation of cpSym2 variants in the library. (B) cpSym2_sel was
selected by an in vivo complementation assay. (C) Four amino acid exchanges (S101I, V140A, T171A, D176G) found in cpSym2_sel are necessary for activity. cpSym2_TrpF
which contains only the four required substitutions, shows a high internal symmetry: The N- and C-terminal halves differ at only six amino acid positions. Residue D130N
which acts as general base (Fig. 1) is indicated in cyan.
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minimal medium. It turned out that the active variant cpSym2_sel
accumulated nine additional amino acid substitutions, which are
shown in Fig. 5B. Our aim was to generate an active artiﬁcial
(ba)8-barrel with maximum internal symmetry. To this end, each
of the nine amino acid exchanges of cpSym2_sel was reversed by
site-directed mutagenesis, and the resulting variants were tested
for their ability to complement the growth deﬁciency of the DtrpF
strain. The results showed that four substitutions, S101I, V140A,
T171A, and D176G, were indispensable for the PRA isomerization
reaction. Thus, the approach with an extremely high mutation rate
turned out to be crucial since the likelihood of identifying four
combined substitutions would have been marginal if we had intro-
duced only a few nucleotide exchanges per gene.
3.3. In vitro PRA isomerization activity of cpSym2_TrpF
Eliminating the ﬁve dispensable amino acid exchanges from
cpSym2_sel resulted in the ﬁnal variant cpSym2_TrpF (Fig. 5C).
The gene for cpSym2_TrpF was cloned from pTNA into the expres-
sion plasmid pET24a(+), and the recombinant protein was
produced in E. coli and puriﬁed by metal chelate afﬁnity chroma-
tography using its C-terminal His6-tag. The catalytic activity of
puriﬁed cpSym2_TrpF was tested in vitro by steady-state enzyme
kinetics. The analysis of the PRA saturation curve (Fig. 6) with
the Michaelis–Menten equation [31] yielded a turnover number
(kcat) of 0.07 min1 and a Michaelis constant (KMPRA) of 7 lM,which is in good accordance with the KDrCdRP value of 4 lM derived
from titration measurements (Fig. 3). Moreover, the catalytic efﬁ-
ciency (kcat/KMPRA) of 167 M1s1 obtained for the artiﬁcial scaffold
cpSym2_TrpF exceeds the (kcat/KMPRA) of 69 M-1s-1 obtained for the
natural scaffold HisF-D130V + D176V. However, the catalytic efﬁ-
ciencies of both constructs are lower by about 4–5 orders of mag-
nitude compared to the natural TrpF enzymes from E. coli and T.
maritima (Table 1).
3.4. Crystal structure of cpSym2_TrpF
In order to elucidate the mechanistic basis of PRA isomerization
by cpSym2_TrpF we crystallized the protein and solved its X-ray
structure at a resolution of 2.3 Å (PDB: 4J9J) Unfortunately, despite
the high afﬁnity for rCdRP, we were unable to get a structure of
cpSym2_TrpF with bound ligand. However, the liganded structure
of HisF-D130V + D176V implied that the PRA isomerization reac-
tion is initiated by the anthranilate moiety of the substrate, which
acts as general acid and protonates its own furanose ring oxygen
(‘‘substrate-assisted catalysis’’). Moreover, D11 acts as the general
base which abstracts a proton from the C20-atom of the Schiff base
reaction intermediate [37] (Fig. 1). Assuming a similar mechanism
for cpSym2_TrpF, its residue D130N which corresponds to D11 of
HisF-D130V + D176V, would act as general base. Superposition of
active cpSym2_TrpF with inactive Sym2 shows that the C-terminal
phosphate binding site, which most probably anchors the substrate
PRA [6], is shifted by 1.5 Å (residues S201, G202 and G203, Fig. 7A)
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Fig. 6. PRA saturation curve of cpSym2_TrpF. Reaction conditions were 50 mM
HEPES pH 7.5, 4 mM EDTA, 4 mM MgCl2, and 2 mM DTT, with PRA concentrations
ranging from 2–50 lM. Reactions were performed at 25 C and initiated by addition
of 10 lM cpSym2_TrpF. Values represent the mean and standard deviation of three
independent measurements. The solid lines show the result of a hyperbolic ﬁt of the
data points, which yielded values for Vmax of 0.7 lMmin1 and for KMPRA of 7 lM.
Table 1
Steady-state kinetic constants of the PRA isomerization reaction.
Enzyme kcat (min1) KMPRA (lM) kcat/KMPRA (M1 s1)
CpSym2_TrpF 0.07 ± 0.02 7 ± 0.7 167
aHisF-D130 V + D176 V 0.073 18 69
beTrpF 2070 12.2 2.8  106
ctTrpF 222 0.28 1.3  107
Reaction conditions: 50 mM Hepes, pH 7.5, 4 mM MgCl2, 4 mM EDTA, 2 mM DTT,
25 C.
a Data taken from [37].
b Data taken from [18].
c Data taken from [46].
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Fig. 8. Schematic overview of laboratory simulation of (ba)8-barrel evolution. All
evolutionary steps leading from recent HisF to TrpF-active cpSym2_TrpF are shown.
Parts are colored according to origin and position (blue: C-terminal half of HisF;
red: N-terminal half of HisF; turquoise: C-terminal half after duplication event, now
N-terminal; orange: N-terminal half, now C-terminal). Positions of amino acid
exchanges leading to respective variants are indicated with lines.
J.M. Sperl et al. / FEBS Letters 587 (2013) 2798–2805 2803due to exchange S101IN. We conclude that this activating amino
acid exchange leads to a reorientation of the substrate at the active
site which allows for the deprotonation of the Schiff base interme-
diate by D130N. Moreover, exchanges V140AN and T171AN are
situated in direct proximity to D130N thereby changing its environ-
ment as well as enhancing its conformational ﬂexibility (Fig. 7B).
The non-resolved amino acid exchanges D176GN and D176VC asA
S101IN S201
G202
G2031.5 Å
B
Fig. 7. Structural superposition of cpSym2_TrpF (cyan) with Sym2 (grey). Ribbon diagram
C-terminal phosphate binding site (residues S201-G203) by 1.5 Å. (B) Exchanges V140A
residue D130N thereby changing its environment.well as D130VC may facilitate binding of rCdRP through reduction
of negative charges in the active center as proposed previously
[37].
4. Conclusions
Our results represent the ultimate step in our laboratory recre-
ation of (ba)8-barrel evolution. By combining rational design with
directed evolution techniques, we have gone all the way from
duplication of a half-barrel sequence, stabilization of the resulting
symmetric protein, introduction of a ligand binding site, and gen-
eration of an enzymatically active (ba)8-barrel that confers a selec-
tive growth advantage (Fig. 8). The success of this simulation has
implications for the design and evolution of enzymes in general
and of (ba)8-barrels in particular. The duplication of existing
protein sequences can lead to the emergence of new, robust pro-
teins. The stability of these resulting proteins can be enhancedD130N
T171 NA
V140 NA
s with relevant amino acids are highlighted as sticks. (A) Exchange S101IN shifts the
N and T171AN are situated in direct proximity to the proposed catalytically active
2804 J.M. Sperl et al. / FEBS Letters 587 (2013) 2798–2805by directed evolution and screening techniques, or simply by opti-
mizing the cut points at which the sequence was excised from the
parental sequence. Once a certain threshold in stability is reached,
the sequence can tolerate a high number of mutations without
compromising the structure, thus allowing the selection of activat-
ing mutations.
Did the natural evolution of the (ba)8-barrel fold follow a
similar route? We do not know exactly the repertoire of sequences
from which nature could choose and whether a recruitment of
half-barrels occurred in the natural evolution of the (ba)8-barrel
fold. However, our ﬁndings show that the assembly of two
identical half-barrels is a plausible strategy for the evolution of
the (ba)8-barrel fold and its manifold enzymatic functions. Not-
withstanding, the fourfold symmetry of a number of (ba)8-barrels
suggests that the smallest independently evolving subdomain
could have been a quarter-barrel [33]. Along these lines, a compu-
tational and experimental analysis indicated that the ancestral
half-barrel of HisF was generated by the duplication and fusion
of a (ba)2-unit [38]. Moreover, the generation of stable and mono-
meric TrpF fragments comprising (ba)1-5b6, and the isolation of
similar fragments of triosephosphate isomerase suggests that
three-quarter-barrels could also have been intermediates in the
evolution of (ba)8-barrel proteins [9,41]. In accordance with this
hypothesis, the members of the S-adenosyl-L-methionine radical
protein family contain not only (ba)8-barrel and (ba)4 half-barrel
but also (ba)6-three-quarter barrel structures [34].
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